Individualization of Music-based Cueing During Gait in Parkinson's Disease.

Individualization of Music-based Cueing During Gait in Parkinson's Disease. An Exploratory Cross-over Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05585489

Acronym

MUSIGAIT

Enrollment

Registered

2022-10-18

Start date

2021-06-22

Completion date

2021-09-30

Last updated

2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Parkinson Disease

Brief summary

Spatio-temporal correction of the step is a key component of gait rehabilitation in Parkinson's disease. Walking rehabilitation techniques using visual or auditory cueing of the cadence or step length have been tested to prevent or correct the lack of consistency of the step. An auditory cue of the duration of the step, encouraging it to be extended according to patient own capacities during gait has been proposed. The cue is integrated into music and is presented in an open-loop approach. The present study aimed to evaluate the effect of the individual music-based cueing of the step length on gait in Parkinson's disease.

Interventions

OTHERGait training with musical cue

Entraînement de 20 minutes de marche à vitesse confortable sur un parcours ovale de 20 mètres au laboratoire ARM avec la technique d'indiçage musical personnalisé de la longueur de pas.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years * Idiopathic Parkinson's disease based on UKPDSBB criteria * 10-meter walking comfortable speed between 0,30 and 1,10 m/s * Capacities to walk with shoes during at least 20 minutes without assistance * Signature of informed consent

Exclusion criteria

* Non-affiliation to Social Security * Person under protection (e.g. under protection of justice) * Auditory disorders without treatment * Cognitive disorders that limit the understanding of the study according to the medical investigator * Other neurological or orthoêdic disorders that addect walking * Participating in another Category 1 or 2 interventional clinical study for the duration of the trial

Design outcomes

Primary

Measure	Time frame	Description
Step length	Before and just after the intervention (day 1)	Step length during confortable gait over 8 meters

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026